BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35405623)

  • 1. USP20 regulates the stability of EMT transcription factor SOX4 and influences colorectal cancer metastasis.
    Guan Y; Jiang SR; Liu JG; Shi JR; Liu ZB
    Pathol Res Pract; 2022 May; 233():153879. PubMed ID: 35405623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA‑129 inhibits colorectal cancer cell proliferation, invasion and epithelial‑to‑mesenchymal transition by targeting SOX4.
    Chen Z; Zhong T; Zhong J; Tang Y; Ling B; Wang L
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of SOX4 is associated with colorectal cancer progression.
    Wang B; Li Y; Tan F; Xiao Z
    Tumour Biol; 2016 Jul; 37(7):9131-7. PubMed ID: 26768610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4.
    Hu F; Min J; Cao X; Liu L; Ge Z; Hu J; Li X
    Biochem Biophys Res Commun; 2016 May; 474(1):35-42. PubMed ID: 27084453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNA-212 acts as a tumor-suppressor in colorectal carcinoma through targeting SOX4.
    Mou TY; Zhang RR; Wang YN
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10751-10760. PubMed ID: 31858542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA TDRG1 promotes the proliferation, migration, and invasion of cervical cancer cells by sponging miR-214-5p to target SOX4.
    Guo M; Lin B; Li G; Lin J; Jiang X
    J Recept Signal Transduct Res; 2020 Jun; 40(3):281-293. PubMed ID: 32106739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-195 inhibits migration, invasion and epithelial-mesenchymal transition (EMT) of endometrial carcinoma cells by targeting SOX4.
    Zhao X; Dai L; Yue Q; Wang H; Wang XU; Li Y; Chen R
    J Biosci; 2019 Dec; 44(6):. PubMed ID: 31894127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
    Vishnubalaji R; Hamam R; Yue S; Al-Obeed O; Kassem M; Liu FF; Aldahmash A; Alajez NM
    Oncotarget; 2016 Jun; 7(24):35789-35802. PubMed ID: 27119506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
    Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
    Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA SNHG5 promotes cervical cancer progression by regulating the miR-132/SOX4 pathway.
    Zhang L; Wu X; Li Y; Teng X; Zou L; Yu B
    Autoimmunity; 2021 Mar; 54(2):88-96. PubMed ID: 33622094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT.
    Ma J; Zhao J; Lu J; Wang P; Feng H; Zong Y; Ou B; Zheng M; Lu A
    Tumour Biol; 2016 Jul; 37(7):9077-88. PubMed ID: 26762412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZFAS1 Promotes Colorectal Cancer Metastasis Through Modulating miR-34b/SOX4 Targeting.
    Deng H; Wang M; Xu Q; Yao H
    Cell Biochem Biophys; 2021 Jun; 79(2):387-396. PubMed ID: 33725330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. USP20 is a predictor of poor prognosis in colorectal cancer and associated with lymph node metastasis, immune infiltration and chemotherapy resistance.
    Jin R; Luo Z; Jun-Li ; Tao Q; Wang P; Cai X; Jiang L; Zeng C; Chen Y
    Front Oncol; 2023; 13():1023292. PubMed ID: 36874086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of SOX4 promotes cell migration and invasion of renal cell carcinoma by inducing epithelial-mesenchymal transition.
    Ruan H; Yang H; Wei H; Xiao W; Lou N; Qiu B; Xu G; Song Z; Xiao H; Liu L; Zhou Y; Hu W; Chen K; Chen X; Zhang X
    Int J Oncol; 2017 Jul; 51(1):336-346. PubMed ID: 28534986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-539 inhibits colorectal cancer progression by directly targeting SOX4.
    Zhao J; Xu J; Zhang R
    Oncol Lett; 2018 Aug; 16(2):2693-2700. PubMed ID: 30013665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deubiquitinase USP20 promotes breast cancer metastasis by stabilizing SNAI2.
    Li W; Shen M; Jiang YZ; Zhang R; Zheng H; Wei Y; Shao ZM; Kang Y
    Genes Dev; 2020 Oct; 34(19-20):1310-1315. PubMed ID: 32943575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX4 induces tumor invasion by targeting EMT-related pathway in prostate cancer.
    Liu Y; Zeng S; Jiang X; Lai D; Su Z
    Tumour Biol; 2017 May; 39(5):1010428317694539. PubMed ID: 28466783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC01605 regulates proliferation, migration and invasion of colorectal cancer cells via targeting miR-3960/SOX11.
    Hu SS; Fu L; Han SY; Li XL; Zhang LD
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1322-1329. PubMed ID: 33629302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.